• Article

Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom

Citation

Wolowacz, S., Brockbank, J., Sunderland, T. J., & Gonschior, A. K. (2013). Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom. Value in Health, 16(7), A526-A526.